Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Weight Loss 1Neoplasms 1Fatigue 1Anorexia 1

Interventions

anamorelin 2Mirtazapine 2Tirzepatide 1Olanzapine 1Octreotide 1Nutritionists 1Nutrition Assessment 1Flurandrenolone 1Exercise 1EOM613 1Diet, Carbohydrate-Restricted 1Diet 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Weight Loss × EOM613 × Clear all
NCT01206335 2012-11-27

Open Label Study With OHR/AVR118 in Advanced Cancer Patients With Anorexia-Cachexia

Ohr Pharmaceutical Inc.

Phase 2 Unknown
20 enrolled

Anorexia, Fatigue, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡